ELVN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Enliven Therapeutics Inc (ELVN) is not a strong buy at the moment given the investor's long-term strategy and beginner level. The technical analysis shows mixed signals, with bearish MACD and neutral RSI, while options data indicates bearish sentiment with a high Put-Call ratio. Financial performance is weak, with declining net income and EPS. There are no significant positive catalysts, news, or recent insider/congressional trading activity to support a buy decision.
The MACD is bearish with a negatively expanding histogram (-0.208). RSI is neutral at 46.899, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 25.824, and resistance is at 29.644. The stock has a 60% chance of declining in the next week and month.
No significant positive catalysts identified. No recent news or insider/congressional trading activity.
Bearish MACD, weak financial performance, and bearish options sentiment with a high Put-Call ratio. The stock is expected to decline slightly in the short term.
In 2025/Q3, revenue remained at 0 with no growth. Net income dropped by -12.99% YoY to -20.15M, and EPS declined by -33.33% YoY to -0.32. Gross margin remains at 0.
No analyst rating or price target data available.
